These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 859630)

  • 21. Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumor cells.
    Lamberts SW; MacLeod RM
    Endocrinology; 1978 Nov; 103(5):1710-7. PubMed ID: 748012
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.
    MacLeod RM; Fontham EH; Lehmeyer JE
    Neuroendocrinology; 1970; 6(5):283-94. PubMed ID: 5482108
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures.
    Malarkey WB; O'Dorisio TM; Kennedy M; Cataland S
    Life Sci; 1981 Jun; 28(22):2489-95. PubMed ID: 7253836
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
    Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
    Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic acid potentiates the inhibitory effect of dopamine on prolactin release in primary cultured rat pituitary cells.
    Shin SH; Stirling R
    J Endocrinol; 1988 Aug; 118(2):287-94. PubMed ID: 3171470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
    MacLeod RM; Lamberts SW
    Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral circulation: effect of stimulation and blockade of dopamine receptors.
    McCulloch J; Harper AM
    Am J Physiol; 1977 Aug; 233(2):H222-7. PubMed ID: 407806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
    Farah JM; Malcolm DS; Mueller GP
    Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine inhibits calcium flux in the 7315a prolactin-secreting pituitary tumour.
    Login IS; Judd AM; Macleod RM
    Cell Calcium; 1988 Feb; 9(1):27-31. PubMed ID: 3359479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassay of rat prolactin. Comparison of rat prolactin preparations isolated from the "granular fraction" of pituitary tumour transplants and from normal pituitary glands.
    Kwa HG; van der Gugten AA; Verhofstad F
    Eur J Cancer (1965); 1969 Dec; 5(6):559-69. PubMed ID: 5386717
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of prolactin secretion by metoclopramide in the rat.
    Carlson HE; Briggs JE; McCallum RW
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):475-8. PubMed ID: 847008
    [No Abstract]   [Full Text] [Related]  

  • 37. The 7315a pituitary tumor is refractory to dopaminergic inhibition of prolactin release but contains dopamine receptors.
    Cronin MJ; Valdenegro CA; Perkins SN; MacLeod RM
    Endocrinology; 1981 Dec; 109(6):2160-6. PubMed ID: 7308146
    [No Abstract]   [Full Text] [Related]  

  • 38. The serum and pituitary prolactin variations under the influence of a pesticide substance in the male rat.
    Simionescu L; Oprescu M; Săhleanu V; Dimitriu V; Ghinea E
    Endocrinologie; 1977; 15(3):181-8. PubMed ID: 918527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of apomorphine and of pimozide on renin secretion in the anaesthetized dog.
    Imbs JL; Schmidt M; Velly J; Schwartz J
    Eur J Pharmacol; 1976 Jul; 38(1):175-8. PubMed ID: 954826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma.
    Vertosick FT
    Neurosurgery; 1985 Feb; 16(2):261-6. PubMed ID: 3974842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.